Category: Prostate Cancer

Benign prostatic hyperplasia, or BPH, is a common prostate enlargement as men age. It is estimated that at least 40% of men have BPH during their fifties, increasing to 90% of men in their eighties. Many men are not troubled by it, but it can create urinary difficulties if the enlargement narrows the urethral passage from the bladder out of the body. keep reading

Despite cancer warnings, let’s face it. Untold millions of meat-lovers—and the restaurants that cater to them—continue to grill meat over high heat or open flames. As we wrote in the original blog, this causes the formation of carcinogens called heterocyclic aromatic amines (HAAs). keep reading

In January, 2018 we posted a blog on several spices that have an observed anti-cancer affect when laboratory-tested on cancer cells or animals. This update focuses on turmeric and a compound derived from it, curcumin. Curcumin has been shown to... keep reading

Here is more recent news about a genomic analysis of prostate tissue from men in the study described below who developed prostate cancer. The research team, including some authors from the original study, tested for trends in gene expression according to the level of ejaculation frequency... keep reading

Research supports the anti-tumor effect of non-psychoactive CBD (cannabidiol), one of 100+ identified plant-derived cannabinoid compounds. For example, Kis et al. note that lab studies have shown a chemopreventive effect of cannabidiol in prostate cancer... keep reading

Here it is, December of 2020. It’s been the Year of the Pandemic, and possibly also the Year of Increased Drinking. A September 29 ABC News story reported a sharp increase in U.S. alcohol consumption—especially among women—perhaps as a way to cope with feelings of isolation, depression and anxiety. keep reading

Here is fantastic news for men who undergo an initial treatment for localized prostate cancer! In November, 2020 the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to RV001, an investigational vaccine against prostate cancer recurrence after primary treatment. RV001 is manufactured by a Swedish pharmaceutical company called RhoVac. Let’s look at the keep reading

NOTE: The following is an update to a blog I posted in early 2020. Metformin red flag, December 2019 I have occasionally reported on studies that link a possible preventive effect against prostate cancer (PCa) with the common diabetes drug, metformin. In February 2020 I notified readers that the FDA had issued a Dec. 2019 keep reading

PLEASE NOTE: Recruitment for this study has closed and the study has concluded.   In keeping with our mission to serve men with prostate cancer, the Sperling Prostate Center (Delray Beach, FL) is assisting in a clinical research study to help develop a next-generation blood test to detect prostate cancer. This study is sponsored by keep reading

Most of the things we worry about rarely come to pass as we imagine. However, when the Director of the National Cancer Institute, Norman E. “Ned” Sharpless, says he’s worried about the impact of the COVID-19 pandemic on cancer patients, there are good grounds for his fears. Dr. Sharpless contributed an editorial, “COVID-19 and Cancer” keep reading